XML 56 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
EMPLOYEE STOCK COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Share-Based Compensation Expense
The following table presents share-based compensation expense and the related tax benefits for the periods indicated:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
($ in thousands)
 
2018
 
2017
 
2018
 
2017
Stock options
 
$
32

 
$
36

 
$
145

 
$
703

Restricted stock awards and units
 
1,366

 
2,185

 
5,128

 
9,167

Stock appreciation rights
 

 

 

 
42

Total share-based compensation expense
 
$
1,398

 
$
2,221

 
$
5,273

 
$
9,912

Related tax benefits
 
$
410

 
$
927

 
$
1,546

 
$
4,122

Unrecognized Share-Based Compensation Expense
The following table presents unrecognized share-based compensation expense as of September 30, 2018:
($ in thousands)
 
Unrecognized Expense
 
Weighted-Average Remaining Expected Recognition Period
Stock option awards
 
$
173

 
1.6 years
Restricted stock awards and restricted stock units
 
10,853

 
2.4 years
Total
 
$
11,026

 
2.4 years
Option Activity
The following table represents stock option activity for the three months ended September 30, 2018:
 
 
Three Months Ended September 30, 2018
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
186,973

 
$
13.54

 
6.3 years
 
$
1,123

Outstanding at end of period
 
186,973

 
$
13.54

 
6.1 years
 
$
1,002

Exercisable at end of period
 
123,125

 
$
13.67

 
5.8 years
 
$
644


The following table represents stock option activity for the nine months ended September 30, 2018:
 
 
Nine Months Ended September 30, 2018
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
210,973

 
$
13.99

 
7.0 years
 
$
1,405

Exercised
 
(24,000
)
 
$
17.50

 
8.2 years
 
$

Outstanding at end of period
 
186,973

 
$
13.54

 
6.1 years
 
$
1,002

Exercisable at end of period
 
123,125

 
$
13.67

 
5.8 years
 
$
644

Nonvested Share
The following table sets forth information regarding unvested stock options for the three and nine months ended September 30, 2018.
 
 
Three Months Ended September 30, 2018
 
Nine Months Ended September 30, 2018
 
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
Outstanding at beginning of period
 
73,324

 
$
13.32

 
105,432

 
$
13.31

Vested
 
(9,476
)
 
$
13.46

 
(41,584
)
 
$
13.32

Outstanding at end of period
 
63,848

 
$
13.30

 
63,848

 
$
13.30

Restricted Stock and Restricted Stock Units Activity
The following table presents unvested restricted stock awards and restricted stock units activity for the three and nine months ended September 30, 2018:
 
 
Three Months Ended September 30, 2018
 
Nine Months Ended September 30, 2018
 
 
Number of Shares
 
Weighted Average Grant Date Fair Value Per Share
 
Number of Shares
 
Weighted
Average Grant
Date Fair Value
Per Share
Outstanding at beginning of period
 
985,237

 
$
18.84

 
911,633

 
$
18.73

Granted (1)
 
41,108

 
$
20.00

 
619,970

 
$
18.92

Vested (1)
 
(68,506
)
 
$
18.02

 
(386,723
)
 
$
18.84

Forfeited (1)
 
(45,140
)
 
$
18.23

 
(232,181
)
 
$
18.27

Outstanding at end of period
 
912,699

 
$
18.99

 
912,699

 
$
18.99


(1)
The number of granted shares/units includes aggregate performance-based shares of 0 and 306,801 for the three and nine months ended September 30, 2018, respectively. The number of vested shares includes aggregate performance-based shares of 0 and 44,817 for the three and nine months ended September 30, 2018, respectively. The number of forfeited shares includes aggregate performance-based shares of 12,958 and 60,378 for the three and nine months ended September 30, 2018, respectively. The vesting of these awards is subject to certain performance targets and goals being met. These performance targets include conditions relating to the Company’s profitability and regulatory standing. The actual amounts of stock released upon vesting will be determined by the Compensation Committee of the Company's Board of Directors upon the Committee's certification of the satisfaction of the target level of performance.
Summary of all Outstanding SARs
The following table represents SARs activity as of and for the three months ended September 30, 2018:
 
 
Three Months Ended September 30, 2018
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
1,559,012

 
$
11.60

 
4.1 years
 
$
12,390

Outstanding at end of period
 
1,559,012

 
$
11.60

 
3.9 years
 
$
11,377

Exercisable at end of period
 
1,559,012

 
$
11.60

 
3.9 years
 
$
11,377

The following table represents SARs activity as of and for the nine months ended September 30, 2018:
 
 
Nine Months Ended September 30, 2018
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
1,559,012

 
$
11.60

 
4.6 years
 
$
14,105

Outstanding at end of period
 
1,559,012

 
$
11.60

 
3.9 years
 
$
11,377

Exercisable at end of period
 
1,559,012

 
$
11.60

 
3.9 years
 
$
11,377